About Eicos Sciences
Eicos Sciences is a company based in San Mateo (United States) founded in 2016. It operates as a B2B. The company has 9 employees as of December 31, 2022. Eicos Sciences offers products and services including Prostacyclin Analogues. Eicos Sciences operates in a competitive market with competitors including Amryt Pharma, Castle Creek Biosciences, QID Pharma and LifeMax, among others.
- Headquarter San Mateo, United States
- Employees 9 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Civi Biopharma, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
9
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Eicos Sciences
Eicos Sciences offers a comprehensive portfolio of products and services, including Prostacyclin Analogues. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops drugs targeting vasodilation and inflammation for rare diseases.
Funding Insights of Eicos Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Eicos Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Eicos Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Eicos Sciences Comparisons
Competitors of Eicos Sciences
Eicos Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amryt Pharma, Castle Creek Biosciences, QID Pharma and LifeMax, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for rare dermatological and orphan diseases are developed.
|
|
| domain | founded_year | HQ Location |
Gene therapy platform for rare disease treatments is developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare genetic dermatology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Develops innovative therapeutic solutions for Netherton syndrome treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Eicos Sciences
Frequently Asked Questions about Eicos Sciences
When was Eicos Sciences founded?
Eicos Sciences was founded in 2016.
Where is Eicos Sciences located?
Eicos Sciences is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
How many employees does Eicos Sciences have?
As of Dec 31, 2022, the latest employee count at Eicos Sciences is 9.
What does Eicos Sciences do?
Eicos Sciences is a biotechnology company focused on researching and developing Prostacyclin analogues, which act as vasodilators with antiplatelet and anti-inflammatory properties. The company targets debilitating conditions like frostbite, systemic sclerosis, and ECMO, where treatment options are scarce. Based in San Mateo, California, it operates as a subsidiary of CiVi Biopharma Holding Corp., aiming to improve patient outcomes through innovative science and therapeutic pipelines.
Who are the top competitors of Eicos Sciences?
Eicos Sciences's top competitors include Castle Creek Biosciences, Amryt Pharma and QID Pharma.
What products or services does Eicos Sciences offer?
Eicos Sciences offers Prostacyclin Analogues.